Walleye Capital
RLYB icon

Walleye Capital’s Rallybio RLYB Stock Holding History

Walleye Capital’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,012
Closed -$526K – 4295
2022
Q4 		$526K Buy
+10,012
New +$591K 0.01% 1417
2022
Q2 		– Sell
-7,443
Closed -$416K – 2678
2022
Q1 		$416K Buy
+7,443
New +$616K 0.01% 1110

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Walleye Capital's RLYB Position: Q1 2023 in Review

Walleye Capital sold out of Rallybio (RLYB) in Q1 2023, closing a stake of 10,012 shares — an estimated $526K sold.

Walleye Capital first reported a position in RLYB in Q1 2022 and held it in 2 quarters. The position peaked at $526K in Q4 2022. 53 funds tracked by Wall St. Rank hold RLYB as of Q1 2023.

  • Walleye Capital reported no remaining Rallybio position as of Q1 2023 after selling out during the quarter.
  • Walleye Capital sold 10,012 Rallybio shares in Q1 2023, an estimated $526K.
  • Walleye Capital first reported a position in Rallybio in Q1 2022 and held it in 2 quarters.
  • Walleye Capital's Rallybio position peaked at $526K in Q4 2022.
  • 53 funds tracked by Wall St. Rank held Rallybio as of Q1 2023.

Based on Walleye Capital's 13F filing for Q1 2023, filed 15 May 2023.